In this edition of Deep Dive, Unpacking complex choreography in the biologics patent dance, Alexion examines the urgent need for accelerated access programmes for rare disease treatments, and Putnam ...
Palo Alto closes privileged access gap with $25B CyberArk acquisition Embedding CyberArk’s PAM into its core platform, Palo Alto is sharpening its Zero Trust posture and intensifying competition in ...